r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

LS

Lynn Seely

Insider · President and CEO · LYEL

Lynn Seely files insider transactions with the SEC as a president and ceo of Lyell Immunopharma (LYEL). We hold 5 disclosed purchases and sales filed since 20 March 2007, 3 of them in the last 90 days.

  • Files forLYEL
  • Disclosed buys and sells5 in all, 3 in the last 90 days
  • Last disclosure25 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 8 June 2022 — 21 August 2026President and CEO · Lyell Immunopharma (LYEL)26 Form 4 lines · source: SEC Form 4
  • Filed 1 July 2026 — 1 July 2026Director · AbCellera Biologics (ABCL)1 Form 4 line · source: SEC Form 4
  • Filed 14 April 2016 — 17 July 2025Director · Blueprint Medicines (BPMC)31 Form 4 lines · source: SEC Form 4
  • Filed 15 May 2017 — 3 April 2020Principal Executive Officer · Myovant Sciences (MYOV)6 Form 4 lines · source: SEC Form 4
  • Filed 16 March 2007 — 17 February 2015Chief Medical Officer · Medivation (MDVN)167 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.